Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016460
Filing Date
2019-11-05
Accepted
2019-11-05 16:08:09
Documents
58
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 762396
2 ex31-1.htm EX-31.1 18378
3 ex31-2.htm EX-31.2 18387
4 ex32-1.htm EX-32.1 7091
5 ex32-2.htm EX-32.2 7259
  Complete submission text file 0001493152-19-016460.txt   3191000

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prvb-20190930.xml EX-101.INS 449880
7 XBRL SCHEMA FILE prvb-20190930.xsd EX-101.SCH 37043
8 XBRL CALCULATION FILE prvb-20190930_cal.xml EX-101.CAL 35712
9 XBRL DEFINITION FILE prvb-20190930_def.xml EX-101.DEF 167258
10 XBRL LABEL FILE prvb-20190930_lab.xml EX-101.LAB 241439
11 XBRL PRESENTATION FILE prvb-20190930_pre.xml EX-101.PRE 223567
Mailing Address P.O. BOX 666 OLDWICK NJ 08858
Business Address P.O. BOX 666 OLDWICK NJ 08858 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 191193340
SIC: 2834 Pharmaceutical Preparations